A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Sydney Children's Hospital, Sydney

Rigshospitalet - Kræftbehandling, Copenhagen

UZ Antwerpen, Edegem

Royal Children's Hospital Melbourne, Parkville

Memorial Sloan-Kettering Cancer Center, New York

Children's Hospital of Philadelphia, Philadelphia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Virginia Oncology Associates, Norfolk

Fundacion Jimenez Diaz (Clinica de la Concepcion), Madrid

Children's Healthcare of Atlanta, Atlanta

Sarah Cannon Research Institute, Nashville

St. Jude Children's Research Hospital, Memphis

University of Michigan, Ann Arbor

Avera Cancer Institute, Sioux Falls

Midwestern Regional Medical Center, Zion

Universitätsklinikum Heidelberg, Heidelberg

Institut Curie - Ulm - Paris, Paris

University of Texas MD Anderson Cancer Center, Houston

Univ.of California-San Diego Moores Cancer Center, La Jolla

Stanford Cancer Center, Palo Alto

Institut Gustave Roussy - Département de Médecine Oncologique, Villejuif

Oregon Health and Science University, Portland

Seattle Children's Hospital, Seattle

National Cancer Center Singapore, Singapore

UCLA Jonsson Comprehensive Cancer Center, Los Angeles

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Tallaght Hospital, Dublin

Ciutat Sanitaria i Universitaria de la Vall d'Hebron, Barcelona